Novo Nordisk filed a trademark infringement and false advertising lawsuit Monday in Tennessee Middle District Court against Indian Lake Medical Weight Loss & Wellness. The court action, filed by King & Spalding and Riley & Jacobson, accuses the defendant of infringing the plaintiff's Ozempic and Wegovy marks in order to sell drug products that falsely claim to contain semaglutide and have FDA approval. Counsel have not yet appeared for the defendant. The case is 3:23-cv-00650, Novo Nordisk A/S et al v. Indian Lake Medical Weight Loss & Wellness Inc.